A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.